Respiration-induced tumour motion can potentially compromise the use of intensity-modulated radiotherapy (IMRT) as a dose escalation tool for lung tumour treatment. We have experimentally investigated the intra-fractional organ motion effects in lung IMRT treatments delivered by multi-leaf collimator (MLC). An in-house made motor-driven platform, which moves sinusoidally with an amplitude of 1 cm and a period of 4 s, was used to mimic tumour motion. Tumour motion was simulated along cranial-caudal direction while MLC leaves moved across the patient from left to right, as in most clinical cases. The dose to a point near the centre of the tumour mass was measured according to geometric and dosimetric parameters from two five-field lung IMRT plans. For each field, measurement was done for two dose rates (300 and 500 MU min(-1)), three MLC delivery modes (sliding window, step-and-shoot with 10 and 20 intensity levels) and eight equally spaced starting phases of tumour motion. The dose to the measurement point delivered from all five fields was derived for both a single fraction and 30 fractions by randomly sampling from measured dose values of each field at different initial phases. It was found that the mean dose to a moving tumour differs slightly (<2-3%) from that to a static tumour. The variation in breathing phase at the start of dose delivery results in a maximum variation around the mean dose of greater than 30% for one field. The full width at half maximum for the probability distribution of the point dose is up to 8% for all five fields in a single fraction, but less than 1-2% after 30 fractions. In general, lower dose rate can reduce the motion-caused dose variation and therefore might be preferable for lung IMRT when no motion mitigation techniques are used. From the two IMRT cases we studied where tumour motion is perpendicular to MLC leaf motion, the dose variation was found to be insensitive to the MLC delivery mode.

Intrafraction organ motion during the dynamic delivery of intensity‐modulated radiation therapy (IMRT) treatment of lung tumors may cause unexpected hot/cold spots within the target volume, due to the interplay effect between tumor motion and multileaf collimator (MLC) leaf motion. In the past, this has been investigated through theoretical analysis, computer simulation, and experimental measurement using an ionization chamber dosimeter. In the work presented here, the interplay effect was studied experimentally in 2D, using Kodak EDR2 films. A five‐field lung IMRT plan was delivered to a solid water phantom with embedded film. The phantom was placed on a motor‐driven platform with a sinusoidal motion to simulate the respiration‐induced tumor motion. The delivery of each field began at one of eight equally spaced initial breathing phases. The dose distribution for each treatment fraction was estimated by combining the dose distributions for all fields with randomly sampled initial breathing phases. The dose variation caused by the interplay effect was estimated by looking at the dose values from 1000 trials of 30 fractions. It was found that, on a day‐to‐day basis, the standard deviation of the dose to a given pixel in the high‐dose region could be as high as 2% to 4% due to the motion interplay effect. After 30 fractions, the standard deviation in the dose to each pixel is reduced to 0.4% to 0.7%. However, compared to the static delivery, the dose distribution from a 30‐fraction case in the presence of motion shows some underdosing in the region of interest. We found that the maximum dose in the target remains within 1% of the maximum dose in the static case, but the minimum dose in the target is most likely to be about 6% lower than the static case. Our results indicate that there can be some underdosing of the tumor due to the interplay effect in lung IMRT delivery over the entire course of a 30‐fraction treatment.PACS number: 87.53.Mr

No abstract

Purpose: Image guided treatment of lung provides the ability to deliver dose precisely to the target, however, lung dose calculation is often difficult and might be the weakest link now in the chain of lung IGRT. The purpose in this work is to find out the accuracy of a common TPS system in lung dose calculation. Method and Materials: So far lung dose measurements have been done only in slab geometry and for a single beam. In this work, we used a realistic lung phantom and delivered all fields of realistic IMRT plans. The phantom is supplied with cylindrical inserts, made of lung, bone, and tissue, which were used to load the dosimetry equipments. The dose to the phantom was calculated, for 10 IMRT treatment plans, with the Corvus system. Validation of the calculated dose was performed with LiF thermoluminescent dosimeters (TLDs) measurement, Ionization chamber measurement, and Monte Carlo simulation. For each treatment plan, the dose was verified at points located in lung, bone, and tissue. Results: The comparison of the collected data shows that the dose to the lung calculated with Corvus was overestimated by 10% relative to the Monte Carlo results, and by 7% relative to the chamber measurements. The TLDs dose results show better agreement to the Monte Carlo results than to the Corvus results. In bone the Monte Carlo agreed well with both TLDs and chamber measurements (within 3.5%) while Corvus dose was 6.5% different. The dose to the tissue shows good agreement (within 2%) between all the dosimetry tools. Conclusion: The dose calculation accuracy in lung has been estimated for IMRT planning system. It indicates some better dose algorithms might be needed in order to have an accuracy of a few percent.